Michael Lishner

8.4k total citations
238 papers, 6.0k citations indexed

About

Michael Lishner is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Michael Lishner has authored 238 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 60 papers in Molecular Biology and 47 papers in Hematology. Recurrent topics in Michael Lishner's work include Cancer Risks and Factors (35 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Multiple Myeloma Research and Treatments (26 papers). Michael Lishner is often cited by papers focused on Cancer Risks and Factors (35 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Multiple Myeloma Research and Treatments (26 papers). Michael Lishner collaborates with scholars based in Israel, Canada and United States. Michael Lishner's co-authors include Gideon Koren, David Pereg, Mordchai Ravid, Liat Drucker, Avi Leader, Avishay Elis, Aliza Amiel, Judith Radnay, Moshe Fejgin and Donna Zemlickis and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Lishner

234 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Lishner	2.3k	1.2k	1.1k	808	770	238	6.0k
Lene Heickendorff	1.2k 0.5×	1.1k 0.9×	558 0.5×	726 0.9×	689 0.9×	158	6.7k
Stig E. Bojesen	1.8k 0.8×	2.4k 2.1×	840 0.8×	365 0.5×	454 0.6×	172	8.3k
Murray B. Urowitz	1.2k 0.5×	1.5k 1.3×	1.4k 1.3×	1.4k 1.7×	1.4k 1.8×	360	19.6k
Gertjan Wolbink	768 0.3×	1.4k 1.2×	1.3k 1.2×	625 0.8×	1.5k 1.9×	204	10.9k
Anil Chandraker	1.6k 0.7×	1.9k 1.6×	785 0.7×	770 1.0×	543 0.7×	194	9.1k
Phillip Ruiz	1.1k 0.5×	1.9k 1.7×	1.3k 1.2×	1.0k 1.3×	441 0.6×	297	11.1k
Irene Helenowski	1.7k 0.8×	898 0.8×	683 0.6×	253 0.3×	249 0.3×	232	5.7k
Michael Gregor	1.3k 0.6×	2.7k 2.3×	1.0k 1.0×	256 0.3×	870 1.1×	200	7.7k
Thomas E. Moon	2.3k 1.0×	2.2k 1.9×	781 0.7×	1.6k 2.0×	491 0.6×	107	7.9k
Frederick P. Ognibene	752 0.3×	819 0.7×	2.1k 2.0×	747 0.9×	985 1.3×	69	6.8k

Countries citing papers authored by Michael Lishner

Since Specialization

Citations

This map shows the geographic impact of Michael Lishner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lishner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lishner more than expected).

Fields of papers citing papers by Michael Lishner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lishner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lishner. The network helps show where Michael Lishner may publish in the future.

Co-authorship network of co-authors of Michael Lishner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lishner. A scholar is included among the top collaborators of Michael Lishner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lishner. Michael Lishner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leader, Avi, Netta Mendelson Cohen, Osnat Itzhaki Ben Zadok, et al.. (2023). Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer. JACC CardioOncology. 5(2). 174–185. 21 indexed citations

Robin, Arthur, Alexander Chemodanov, Mario Lebendiker, et al.. (2021). Fighting SARS-CoV-2 with green seaweed Ulva sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in in vitro Vero-E6 cells assay. PeerJ. 9. e12398–e12398. 15 indexed citations

Lishner, Michael, et al.. (2019). The Muddied Waters of Ibrutinib Therapy. Acta Haematologica. 141(4). 209–213. 3 indexed citations

Bentur, Ohad S., et al.. (2017). The management of hodgkin lymphomas in pregnancies. European Journal Of Haematology. 99(5). 385–391. 17 indexed citations

Attar‐Schneider, Oshrat, et al.. (2017). Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells’ phenotype and translation initiation. Carcinogenesis. 38(7). 708–716. 35 indexed citations

Matalon, Shelly Tartakover, Gali Epstein Shochet, Liat Drucker, & Michael Lishner. (2015). [THE EFFECT OF PREGNANCY ON BREAST CANCER].. PubMed. 154(8). 530–4, 539. 1 indexed citations

Shochet, Gali Epstein, Meir Pomeranz, Ami Fishman, et al.. (2014). The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression. Molecular Human Reproduction. 20(5). 422–432. 4 indexed citations

Attar‐Schneider, Oshrat, Liat Drucker, Victoria Zismanov, Shelly Tartakover‐Matalon, & Michael Lishner. (2014). Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma. Cellular Signalling. 26(9). 1878–1887. 19 indexed citations

Elis, Avishay & Michael Lishner. (2012). Non-every day statin administration — A literature review. European Journal of Internal Medicine. 23(5). 474–478. 16 indexed citations

10.

Elis, Avishay, et al.. (2009). Cryptococcal meningitis in chronic lymphocytic leukemia patients.. PubMed. 11(7). 437–9. 13 indexed citations

11.

Lishner, Michael, et al.. (2007). Maternal and Fetal Effects of Systemic Therapy in the Pregnant Woman with Cancer. PubMed. 178. 21–38. 16 indexed citations

12.

Elis, Avishay, et al.. (2006). Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?. PubMed. 8(12). 840–2. 1 indexed citations

13.

Drucker, Liat, Shelly Tartakover‐Matalon, Victoria Zismanov, et al.. (2005). Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines. Carcinogenesis. 27(2). 197–204. 37 indexed citations

14.

Radnay, Judith, et al.. (2003). Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Experimental Hematology. 31(9). 779–783. 63 indexed citations

15.

Szyper‐Kravitz, Martine, Orit Uziel, Hava Shapiro, et al.. (2003). Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34⁺ haematopoietic cells and may prevent telomere attrition after chemotherapy. British Journal of Haematology. 120(2). 329–336. 26 indexed citations

16.

Amiel, Aliza, Yona Kitay‐Cohen, Moshe Fejgin, & Michael Lishner. (2000). Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Experimental Hematology. 28(2). 156–160. 27 indexed citations

17.

Lishner, Michael, et al.. (1999). Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease. Medical Hypotheses. 53(5). 447–449. 7 indexed citations

18.

Sagman, Uri, Michael Lishner, Ellen Maki, et al.. (1992). Second primary malignancies following diagnosis of small-cell lung cancer.. Journal of Clinical Oncology. 10(10). 1525–1533. 61 indexed citations

19.

Lishner, Michael, et al.. (1991). Diffuse Large-Cell Lymphoma in the Elderly: Does a Clinically Indolent Subset Exist?. Leukemia & lymphoma. 4(3). 205–209. 1 indexed citations

20.

Lishner, Michael, Bruce Patterson, Rita A. Kandel, et al.. (1990). Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer. 65(3). 473–476. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact